Kenneth G. Linden

1.2k total citations
37 papers, 778 citations indexed

About

Kenneth G. Linden is a scholar working on Dermatology, Oncology and Epidemiology. According to data from OpenAlex, Kenneth G. Linden has authored 37 papers receiving a total of 778 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Dermatology, 13 papers in Oncology and 10 papers in Epidemiology. Recurrent topics in Kenneth G. Linden's work include Cutaneous Melanoma Detection and Management (9 papers), Skin Protection and Aging (7 papers) and Nonmelanoma Skin Cancer Studies (6 papers). Kenneth G. Linden is often cited by papers focused on Cutaneous Melanoma Detection and Management (9 papers), Skin Protection and Aging (7 papers) and Nonmelanoma Skin Cancer Studies (6 papers). Kenneth G. Linden collaborates with scholars based in United States, Germany and Taiwan. Kenneth G. Linden's co-authors include Gerald D. Weinstein, Ronald J. Barr, Alice B. Gottlieb, John Koo, Gerald G. Krueger, Jaye L. Viner, Sewon Kang, Jerome L. Shupack, Mark Lebwohl and Charles N. Ellis and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, The American Journal of Medicine and Journal of Investigative Dermatology.

In The Last Decade

Kenneth G. Linden

30 papers receiving 738 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kenneth G. Linden United States 14 279 258 175 164 151 37 778
Wendy Cantrell United States 14 325 1.2× 267 1.0× 298 1.7× 82 0.5× 64 0.4× 31 765
Nicoletta Bernardini Italy 15 444 1.6× 372 1.4× 138 0.8× 158 1.0× 230 1.5× 83 1.0k
Laura Diluvio Italy 15 526 1.9× 356 1.4× 280 1.6× 159 1.0× 93 0.6× 61 880
Nevena Skroza Italy 15 416 1.5× 260 1.0× 209 1.2× 193 1.2× 264 1.7× 91 1.0k
Cinzia Ricci Italy 16 163 0.6× 322 1.2× 91 0.5× 284 1.7× 202 1.3× 42 917
Bernice Y. Kwong United States 17 279 1.0× 386 1.5× 134 0.8× 477 2.9× 194 1.3× 67 1.1k
I. Christiansen Norway 3 436 1.6× 434 1.7× 193 1.1× 172 1.0× 131 0.9× 6 972
Pablo Coto‐Segura Spain 18 427 1.5× 656 2.5× 124 0.7× 145 0.9× 201 1.3× 60 1.1k
Andrew M. Guzman United States 7 548 2.0× 828 3.2× 79 0.5× 183 1.1× 187 1.2× 7 1.1k
Ersilia Tolino Italy 12 312 1.1× 188 0.7× 113 0.6× 150 0.9× 209 1.4× 65 749

Countries citing papers authored by Kenneth G. Linden

Since Specialization
Citations

This map shows the geographic impact of Kenneth G. Linden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth G. Linden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth G. Linden more than expected).

Fields of papers citing papers by Kenneth G. Linden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth G. Linden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth G. Linden. The network helps show where Kenneth G. Linden may publish in the future.

Co-authorship network of co-authors of Kenneth G. Linden

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth G. Linden. A scholar is included among the top collaborators of Kenneth G. Linden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth G. Linden. Kenneth G. Linden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tran, Tu, Bonnie Lee, Linda Doan, et al.. (2025). Patient Characteristics and Outcomes in Clinically Misdiagnosed Patients With Merkel Cell Carcinoma. Journal of Surgical Research. 309. 71–79.
2.
Linden, Kenneth G., et al.. (2025). Diagnostic Utility of Molecular Profiling in a Giant Cellular Blue Nevus. American Journal of Dermatopathology. 48(2). 94–99.
3.
Pham, Christine, et al.. (2024). A rare case of pediatric cutaneous bullous mastocytosis. JAAD Case Reports. 57. 14–17.
4.
Navarrete‐Dechent, Cristián, Ashfaq A. Marghoob, Jennifer Stein, et al.. (2024). The Impact of Melanoma Imaging Biomarker Cues on Detection Sensitivity and Specificity in Melanoma versus Clinically Atypical Nevi. Cancers. 16(17). 3077–3077.
5.
Linden, Kenneth G., et al.. (2022). Doxycyline-induced hypoglycemia in a nondiabetic older woman. JAAD Case Reports. 48. 33–35.
6.
Kraus, Christina N., et al.. (2021). A case of acanthosis nigricans–like mycosis fungoides. JAAD Case Reports. 16. 144–148. 3 indexed citations
7.
Doan, Linda, et al.. (2020). A retrospective, cross‐sectional study characterizing site‐specific and laterality patterns of keratoacanthomas. International Journal of Dermatology. 60(3). e81–e82. 2 indexed citations
8.
Choi, Franchesca, et al.. (2019). Programmed cell death 1 protein and programmed death-ligand 1 inhibitors in the treatment of nonmelanoma skin cancer: A systematic review. Journal of the American Academy of Dermatology. 82(2). 440–459. 34 indexed citations
9.
Korta, Dorota Z., et al.. (2017). Melanoma arising in an ovarian cystic teratoma: a systematic review of presentation, treatment, and outcomes. Archives of Gynecology and Obstetrics. 296(3). 397–404. 4 indexed citations
10.
Linden, Kenneth G., Sancy A. Leachman, Jonathan S. Zager, et al.. (2014). A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial of Lovastatin for Various Endpoints of Melanoma Pathobiology. Cancer Prevention Research. 7(5). 496–504. 20 indexed citations
11.
Elmets, Craig A., Jaye L. Viner, Alice P. Pentland, et al.. (2010). Chemoprevention of Nonmelanoma Skin Cancer With Celecoxib: A Randomized, Double-Blind, Placebo-Controlled Trial. JNCI Journal of the National Cancer Institute. 102(24). 1835–1844. 167 indexed citations
12.
Rietkerk, William, Jason M. Phillips, Jashin J. Wu, et al.. (2010). Medical Students Educate Teens About Skin Cancer: What Have We Learned?. Journal of Cancer Education. 26(1). 153–155. 10 indexed citations
13.
Linden, Kenneth G., et al.. (2005). Netherton syndrome: A case report and review of the literature. International Journal of Dermatology. 45(6). 693–697. 62 indexed citations
14.
Cassarino, David S., Kenneth G. Linden, & Ronald J. Barr. (2005). Cutaneous Keratocyst Arising Independently of the Nevoid Basal Cell Carcinoma Syndrome. American Journal of Dermatopathology. 27(2). 177–178. 18 indexed citations
15.
Gottlieb, Alice B., Sewon Kang, Kenneth G. Linden, et al.. (2004). Evaluation of safety and clinical activity of multiple doses of the anti-CD80 monoclonal antibody, galiximab, in patients with moderate to severe plaque psoriasis. Clinical Immunology. 111(1). 28–37. 35 indexed citations
16.
Linden, Kenneth G.. (2004). Screening and early detection of skin cancer. Current Oncology Reports. 6(6). 491–496. 11 indexed citations
17.
Linden, Kenneth G., Philip M. Carpenter, Christine E. McLaren, et al.. (2003). Chemoprevention of Nonmelanoma Skin Cancer: Experience with a Polyphenol from Green Tea. Recent results in cancer research. 163. 165–171. 26 indexed citations
18.
Barr, Ronald J., et al.. (2003). Analysis of Heterogeneity of Atypia Within Melanocytic Nevi. Archives of Dermatology. 139(3). 289–92. 14 indexed citations
19.
Linden, Kenneth G., et al.. (2002). Desmoplastic malignant melanoma of the lip: A report of 6 cases and review of the literature. Journal of the American Academy of Dermatology. 47(6). 863–868. 9 indexed citations
20.
Linden, Kenneth G. & Gerald D. Weinstein. (1999). Psoriasis: current perspectives with an emphasis on treatment. The American Journal of Medicine. 107(6). 595–605. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wendy Cantrell Breakdown of academic impact, for papers by Nicoletta Bernardini Breakdown of academic impact, for papers by Laura Diluvio Breakdown of academic impact, for papers by Nevena Skroza Breakdown of academic impact, for papers by Cinzia Ricci Breakdown of academic impact, for papers by Bernice Y. Kwong Breakdown of academic impact, for papers by I. Christiansen Breakdown of academic impact, for papers by Pablo Coto‐Segura Breakdown of academic impact, for papers by Andrew M. Guzman Breakdown of academic impact, for papers by Ersilia Tolino
Rankless by CCL
2026